Oncolytics Biotech® Inc. Announces Completion of Patient Enrollment in U.S. Randomized Phase II Pancreatic Cancer Study
CNW Group - Tue Jul 08, 5:30AM CDT
Oncolytics Biotech Inc. ("Oncolytics"
Oncolytics Biotech® Inc. Announces Director Election Results from its Annual Meeting of Shareholders
PR Newswire - Thu Jun 19, 5:30AM CDT
Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY) announced today that all nominees listed in the management information circular dated May 9, 2014 were elected as directors at its 2014 Annual Meeting of Shareholders, held on Wednesday June 18th, 2014. On a vote by ballot, the following 10 nominees proposed by management were elected as Directors of Oncolytics to serve until the Company`s next Annual Meeting of Shareholders or until their successors are elected or appointed, with shares represented at the meeting voting in favour of individual nominees as follows:
Oncolytics Biotech® Inc. Announces Details of 2014 Annual Meeting of Shareholders
PR Newswire - Mon Jun 16, 5:30AM CDT
Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY) announced today that its 2014 Annual Meeting of Shareholders will be held on Wednesday June 18th, 2014 at 4:30pm ET at the TMX Broadcast Centre, 130 King Street West, Toronto, ON
Media Advisory - Oncolytics Biotech® Inc. to Participate in Jefferies 2014 Global Healthcare Conference
CNW Group - Mon Jun 02, 5:30AM CDT
Dr. Brad Thompson, President and CEO of Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY), will participate in the Jefferies 2014 Global Healthcare Conference in a session on Tuesday June 3(rd), 2014 at 4:00 p.m. ET. The conference takes place from June 2(nd) to 5(th) in New York, NY.
Oncolytics Biotech® Inc. Announces Nomination of Two New Directors
PR Newswire - Wed May 21, 6:16PM CDT
Oncolytics Biotech Inc. (TSX:ONC) (NASDAQ:ONCY) ("Oncolytics" or the "Company"
Oncolytics Biotech® Inc. Collaborators to Present Positive Brain Cancer Clinical Trial Data at the 50th Annual ASCO Meeting
CNW Group - Tue May 20, 5:30AM CDT
Oncolytics Biotech Inc. ("Oncolytics"
Oncolytics Biotech® Inc. Announces 2013 Year End Results
CNW Group - Thu Mar 13, 5:30AM CDT
Oncolytics Biotech Inc. (TSX:ONC, NASDAQ:ONCY) ("Oncolytics" or the "Company"
MEDIA ADVISORY - Oncolytics Biotech® Inc. to Participate in the 34th Annual Cowen and Company Healthcare Conference
PR Newswire - Tue Mar 04, 3:00PM CST
Dr. Brad Thompson, President and CEO of Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY), will participate in the 34th Annual Cowen and Company Healthcare Conference in a session on Wednesday March 5th, 2014 at 8:40 a.m. ET. The conference takes place from March 3rd to 5th at the Boston Marriott Copley Place in Boston, MA.
Oncolytics Biotech® Inc. Announces Initial US$1.0 Million Investment and Up to US$25.0 Million Common Share Purchase Agreement with Lincoln Park Capital Fund, LLC
PR Newswire - Thu Feb 27, 8:26AM CST
Oncolytics Biotech Inc. ("Oncolytics" or the "Company"
Media Advisory - Oncolytics Biotech® Inc. to Participate in 2014 RBC Capital Markets Global Healthcare Conference
PR Newswire - Tue Feb 25, 5:30AM CST
Dr. Brad Thompson, President and CEO of Oncolytics Biotech Inc. (TSX: ONC) (NASDAQ: ONCY), will participate in the 2014 RBC Capital Markets Global Healthcare Conference in a session on Wednesday February 26th, 2014 at 8:30 a.m. ET. The conference will take place on February 25th and 26th in New York, NY at the New York Palace Hotel.